Send feedback

DOT1L p.Asp155=

c.465C>T · rs11879054 · VCV777359

Benign Multiple submitters
Classification
Benign
ClinVar
Review
Multiple submitters ★★☆☆
ClinVar · 2 submitters
gnomAD v4.1
Rare
low-frequency (popmax 1.31%, afr)

Computational evidence

Protein change
Missense predictors do not apply to this variant type; conservation carries the signal.
Splicing
SpliceAI—not assessed · no allele here is in the release
Constraint at this position
ConservationphyloP 3.2GERP -1.2, phastCons 1
Overall
CADD8.039PHRED · no single calibrated threshold — expert panels disagree

Population frequency

gnomAD v4.1 · exomes + genomes
Grpmax group 1.31% African / African-American · 979/75,004 alleles
Filtering AF 1.24% ClinGen BA1/BS1 input FAF95, joint · FAF99 1.21%
Overall 0.0744% 1,201/1,613,910 alleles · low-frequency
Ancestry group Frequency 1 in
African / African-Americangrpmax 1.31% 77
Admixed American 0.0967% 1,035
Remaining individualsnot grpmax-eligible 0.072% 1,389
Middle Eastern 0.033% 3,031
European (non-Finnish) 0.00932% 10,727
South Asian 0.00769% 13,012

Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.

Variant & gene context

Gene
DOT1L
Protein
p.Asp155=
Coding
c.465C>T
MANE Select
NM_032482
dbSNP
rs11879054
Type
single nucleotide variant
Location
chr19:2191212 (GRCh38)
Gene constraint
LOEUF 0.321 · pLI 1.00 (gnomAD)
Structure
AlphaFold pLDDT 54.11 · 48 PDB
Residue 155
the dot1 domain; a β-strand
Full DOT1L gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Similar variants

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/dot1l-p-asp155 (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown